May 1, 2017
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Biohaven Pharmaceutical Holding Company Ltd.
Registration Statement on Form S-1 (SEC File No. 333-217214)
Ladies and Gentlemen:
In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of Biohaven Pharmaceutical Holding Company Ltd. that the effective date of the Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., Eastern time, on May 3, 2017, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Act, please be advised that we and the other prospective underwriters have distributed approximately 2,682 copies of the Preliminary Prospectus dated April 24, 2017 (the “Preliminary Prospectus”) through the date hereof, to underwriters, dealers, institutions and others.
In connection with the Preliminary Prospectus distribution for the above-referenced issue, we hereby confirm that we are, and the other prospective underwriters have confirmed that they are, complying with the 48-hour requirement as promulgated by Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Remainder of Page Left Blank Intentionally]
Very truly yours,
MORGAN STANLEY & CO. LLC
PIPER JAFFRAY & CO.
As Representatives
By: | MORGAN STANLEY & CO. LLC |
| |
|
|
| |
|
|
| |
By: | /s/ Kathy Bergsteinsson |
| |
| Name: | Kathy Bergsteinsson |
|
| Title: | Managing Director |
|
|
|
|
|
|
|
|
|
By: | PIPER JAFFRAY & CO. |
| |
|
|
|
|
|
|
|
|
By: | /s/ Christie L. Christina |
| |
| Name: | Christie L. Christina |
|
| Title: | Managing Director |
|
